Gambro signs $142 million loan:
This article was originally published in Clinica
Executive Summary
Swedish dialysis company Gambro has signed a 10-year E150m ($142m) loan with the European Investment Bank. The funds will support the company's R&D investments at two new production sites in Lund, Sweden and Hechingen, Germany. The loan will also be put towards the construction of two plants - in Hechingen and Meyzieu, France - for the manufacture of synthetic dialysers.